Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Immune memory from smallpox vaccination lasts more 50 years, according to Emory research

11.11.2003


Immune memory after smallpox vaccination persists for at least 50 years in immunized individuals, according to research conducted by scientists at the Emory Vaccine Center and Emory University School of Medicine. This is good news, since the findings, published in the Nov. 15 issue of the Journal of Immunology, suggest that individuals vaccinated against smallpox prior to the end of the smallpox vaccination program in 1972 may still retain at least some protection against smallpox.



Rafi Ahmed, PhD, Georgia Research Alliance Eminent Scholar and director of the Emory Vaccine Center, was principal investigator of the research study, and Shane Crotty, PhD, formerly at Emory University School of Medicine and currently a faculty member at The La Jolla Institute for Allergy and Immunology, was first author. Other members of the research team included Emory microbiologist John Glidewell, Phil Felgner, and Luis Villarreal of the University of California, Irvine, and Huw Davies of King’s College London.

Although scientists have known that acute viral infections and vaccines produce two types of long-term immune memory that provide protection against disease, they are still learning the details of these immune mechanisms.


Using a new blood test they developed to assess human antigen-specific immunity, the Emory scientists measured memory B cell responses in individuals recently vaccinated with smallpox vaccine (DryVax), in unvaccinated individuals, and in individuals vaccinated between three months and 60 years earlier. The recently vaccinated group showed a significant virus-specific memory B cell response to vaccinia, while the unvaccinated individuals were negative for vaccinia virus-specific memory B cells. Vaccinia virus-specific B cells were detected in most of the previously vaccinated individuals in the study, including those vaccinated up to 60 years after vaccination.

The scientists found that virus-specific memory B cells initially declined after smallpox immunization, but then reached a plateau approximately ten times lower than their peak, where they remained stable for more than 50 years. Although there were significantly fewer memory B cells in the most recently vaccinated group compared to those vaccinated decades earlier, there was no significant change in B cell memory between 20 and 60 years after vaccination. In addition, individuals vaccinated against smallpox maintained anti-smallpox antibodies in their blood for at least 60 years after vaccination, with no indication of decline between 1 and 60 years.

In humoral immunity, the body’s first line of defense against infection is antibodies produced by B cells, which are the primary measure of immunity for most vaccines. Memory B cells are responsible for stimulating a rapid antibody response after re-exposure to infection. In cellular immunity, activated T cells kill specific virus-infected cells and also produce cytokines –– proteins that prevent the growth of viruses and make cells resistant to viral infection. Previous studies in mice by Dr. Ahmed have shown that B cell memory can persist even without re-exposure to viral antigens, but this had not yet been demonstrated in humans.

In order to test the functionality of the memory B cells, the scientists revaccinated a group of test subjects who had been vaccinated between 22 and 48 years earlier, and detected 20-fold increases in vaccinia-virus antibodies after the second vaccination. They also tested antibody response to a specific viral protein. In previously immunized individuals they detected an antibody response prior to booster immunization as well as a strong response four weeks after booster immunization. In newly vaccinated individuals, however, the antibody response to the specific viral protein was virtually undetectable.

"The fact that there was an antibody response to this viral protein in individuals vaccinated years earlier, but no response in recently vaccinated individuals, demonstrates the potency and value of maintaining a pool of memory B cells for decades after vaccination," notes Dr. Crotty. The researchers also measured vaccinia-virus-specific T cells, and found that although the level of T cells declined gradually over time, the cells still were present even decades after immunization in most study subjects.

"Immune memory to smallpox vaccination is an excellent benchmark to help us understand the mechanisms of good vaccines and also to understand the longevity and stability of immune memory in the absence of revaccination or disease," said Dr. Ahmed. "Our findings may be useful as decisions are made about re-instituting a smallpox vaccination program. And because smallpox has an incubation period of from 12 to 14 days, this provides a window of opportunity for memory B and T cells to expand and attack the infection before the onset of clinical disease."

Dr. Crotty said, "Our findings may help assist health authorities in their decision-making process about updates or changes to the smallpox vaccination program. Our work has not shown that these people would be protected, because that cannot be directly tested, and this is an important point. But, our study does show that people maintain immune memory against smallpox for many decades, and hopefully those levels of immune memory would provide at least some amount of protection against smallpox."

Holly Korschun | EurekAlert!
Further information:
http://www.emory.edu/

More articles from Health and Medicine:

nachricht New study points the way to therapy for rare cancer that targets the young
22.11.2017 | Rockefeller University

nachricht Penn study identifies new malaria parasites in wild bonobos
21.11.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Frictional Heat Powers Hydrothermal Activity on Enceladus

Computer simulation shows how the icy moon heats water in a porous rock core

Heat from the friction of rocks caused by tidal forces could be the “engine” for the hydrothermal activity on Saturn's moon Enceladus. This presupposes that...

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Underwater acoustic localization of marine mammals and vehicles

23.11.2017 | Information Technology

Enhancing the quantum sensing capabilities of diamond

23.11.2017 | Physics and Astronomy

Meadows beat out shrubs when it comes to storing carbon

23.11.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>